Clinical Trial Update: Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML [Phase 2]

View source ↗

Summary

Phase 2 trial investigating chemotherapy, total-body irradiation, donor NK cell infusion, Aldesleukin, and umbilical cord blood transplant for relapsed or refra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Aldesleukin (interleukin-2)
• Donor natural killer (NK) cell infusion (natural killer cells)
• Total Body Irradiation
• UCB transplant (umbilical cord blood transplant)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2012-07-16